Nuclear medicine vendor ADAC Laboratories has adopted a shareholders'rights plan designed to protect its shareholders' interests inthe event of an unsolicited takeover of the Milpitas, CA, company.ADAC said that the plan was not adopted in response to
Nuclear medicine vendor ADAC Laboratories has adopted a shareholders'rights plan designed to protect its shareholders' interests inthe event of an unsolicited takeover of the Milpitas, CA, company.ADAC said that the plan was not adopted in response to any hostiletakeover effort, and the company's board was not aware of anysuch effort.
©1991 - 2001
CMP Media, Inc.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.